SPIA
AVDL

Steward Partners Investment Advisory’s Avadel Pharmaceuticals AVDL Stock Holding History

Steward Partners Investment Advisory’s Portfolio AVDL Stock Details AVDL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-2,000
Closed -$26.2K – 3978
2024
Q3 		$26.2K Sell
2,000
-300
-13% -$4.57K ﹤0.01% 2540
2024
Q2 		$32.3K Hold
2,300
– – ﹤0.01% 2307
2024
Q1 		$38.8K Hold
2,300
– – ﹤0.01% 2229
2023
Q4 		$32.5K Hold
2,300
– – ﹤0.01% 2155
2023
Q3 		$23.7K Hold
2,300
– – ﹤0.01% 2227
2023
Q2 		$37.9K Hold
2,300
– – ﹤0.01% 1999
2023
Q1 		$21.1K Hold
2,300
– – ﹤0.01% 2230
2022
Q4 		$16.5K Hold
2,300
– – ﹤0.01% 2335
2022
Q3 		$12K Hold
2,300
– – ﹤0.01% 2436
2022
Q2 		$6K Buy
2,300
+1,500
+188% +$6.16K ﹤0.01% 2672
2022
Q1 		$5K Buy
800
+500
+167% +$3.44K ﹤0.01% 2865
2021
Q4 		$2K Hold
300
– – ﹤0.01% 2999
2021
Q3 		$3K Hold
300
– – ﹤0.01% 2907
2021
Q2 		$2K Sell
300
-14,302
-98% -$114K ﹤0.01% 6852
2021
Q1 		$132K Buy
14,602
+8,052
+123% +$65.1K ﹤0.01% 1483
2020
Q4 		$44K Sell
6,550
-2,000
-23% -$12.5K ﹤0.01% 1719
2020
Q3 		$43K Buy
8,550
+1,980
+30% +$14.4K ﹤0.01% 1561
2020
Q2 		$53K Buy
6,570
+520
+9% +$4.58K ﹤0.01% 1386
2020
Q1 		$48K Buy
6,050
+1,750
+41% +$13.4K ﹤0.01% 1275
2019
Q4 		$32K Buy
4,300
+4,000
+1,333% +$21.1K ﹤0.01% 1576
2019
Q3 		$1K Hold
300
– – ﹤0.01% 2494
2019
Q2 		$0 Buy
+300
New +$516 ﹤0.01% 2607
2018
Q4 		– Sell
-300
Closed -$1K – 867
2018
Q3 		$1K Hold
300
– – ﹤0.01% 2466
2018
Q2 		$2K Hold
300
– – ﹤0.01% 2194
2018
Q1 		$2K Hold
300
– – ﹤0.01% 1987
2017
Q4 		$2K Buy
+300
New +$2.81K ﹤0.01% 1683

Other funds holding AVDL

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
GJL
Gendell Jeffrey L $7.34B AUM 183.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
WE
Wealth Effects Boston, Massachusetts $370M AUM 97.79% 1-Year Est. Return

Steward Partners Investment Advisory's AVDL Position: Q4 2024 in Review

Steward Partners Investment Advisory sold out of Avadel Pharmaceuticals (AVDL) in Q4 2024, closing a stake of 2,000 shares — an estimated $26.2K sold.

Steward Partners Investment Advisory first reported a position in AVDL in Q4 2017 and held it in 26 quarters. The position peaked at $132K in Q1 2021. 159 funds tracked by Wall St. Rank hold AVDL as of Q4 2024.

  • Steward Partners Investment Advisory reported no remaining Avadel Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • Steward Partners Investment Advisory sold 2,000 Avadel Pharmaceuticals shares in Q4 2024, an estimated $26.2K.
  • Steward Partners Investment Advisory first reported a position in Avadel Pharmaceuticals in Q4 2017 and held it in 26 quarters.
  • Steward Partners Investment Advisory's Avadel Pharmaceuticals position peaked at $132K in Q1 2021.
  • 159 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q4 2024.

Based on Steward Partners Investment Advisory's 13F filing for Q4 2024, filed 6 Feb 2025.